US
Udayalakshmi Suresh
About Udayalakshmi Suresh
Data last updated:
Udayalakshmi Suresh is a Director at Atisa Life Sciences Private Limited (since 2025) and Director at Serind Pharma Private Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹16.7 Lakh; the largest is Atisa Life Sciences Private Limited at ₹13.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Jul 2025 | 2010 | ₹13.5 Lakh (FY 2025) | Active | |
| Director | 16 Jul 2025 | 2017 | ₹3.2 Lakh (FY 2020) | Active |
Board colleagues of Udayalakshmi Suresh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sandhya Nandiraju | 07697975 | Atisa Life Sciences Private Limited , Serind Pharma Private Limited | Director |
| Somasundaram Shanmugam | 02425917 | Atisa Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Udayalakshmi Suresh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Udayalakshmi Suresh
Udayalakshmi Suresh currently holds 2 directorships: Atisa Life Sciences Private Limited (Director, since 31 Jul 2025, revenue ₹13.5 Lakh (FY 2025)); Serind Pharma Private Limited (Director, since 16 Jul 2025, revenue ₹3.2 Lakh (FY 2020)).
Udayalakshmi Suresh was first appointed on 16 Jul 2025 as Director at Serind Pharma Private Limited.
The 2 current companies of Udayalakshmi Suresh that report revenue have a combined latest revenue of ₹16.7 Lakh: Atisa Life Sciences Private Limited ₹13.5 Lakh (FY 2025); Serind Pharma Private Limited ₹3.2 Lakh (FY 2020).
The current boards of Udayalakshmi Suresh's companies include Sandhya Nandiraju (Atisa Life Sciences Private Limited), Somasundaram Shanmugam (Atisa Life Sciences Private Limited).